Researchers believe a simple blood test could flag people who are in the early stages of Alzheimer's, as well as spotting ...
The world’s largest study of proteins circulating the human body will begin in the UK this month, with the aim of pinpointing ...
Use of the treatment has soared in popularity in recent years now taken by 2.6million women in England according to the ...
Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...
Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...
For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...
A study has found cardiovascular conditions such as high blood pressure and diabetes, which are known to contribute to brain blood vessel damage in younger populations, not to be associated with an ...
A study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...
Summary: A new study has identified a biomarker, DTI-ALPS, which connects glymphatic system dysfunction to vascular dementia.
Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...